These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21538943)

  • 41. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
    Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N
    Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Editorial: Special issue on the 7th Symposium of the EWDTS on Workplace Drug Testing.
    Agius R
    Drug Test Anal; 2012 Feb; 4(2):59-61. PubMed ID: 22362569
    [No Abstract]   [Full Text] [Related]  

  • 45. Types of drug-testing programmes in the workplace.
    Mørland J
    Bull Narc; 1993; 45(2):83-113. PubMed ID: 7920543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction.
    Kunkel F; Fey E; Borg D; Stripp R; Getto C
    J Opioid Manag; 2015; 11(5):435-42. PubMed ID: 26535971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies, and laboratories that have withdrawn from the program--SAMHSA. Notice.
    Fed Regist; 1998 Feb; 63(21):5394-6. PubMed ID: 10177334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The detection of illicit drugs in oral fluid: another potential strategy to reduce illicit drug-related harm.
    Dyer KR; Wilkinson C
    Drug Alcohol Rev; 2008 Jan; 27(1):99-107. PubMed ID: 18034388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interpretation of Workplace Tests for Cannabinoids.
    Kulig K
    J Med Toxicol; 2017 Mar; 13(1):106-110. PubMed ID: 27686239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Workplace drug testing, different matrices different objectives.
    Tsanaclis LM; Wicks JF; Chasin AA
    Drug Test Anal; 2012 Feb; 4(2):83-8. PubMed ID: 22362574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status of accreditation for drug testing in hair.
    ; Cooper G; Moeller M; Kronstrand R
    Forensic Sci Int; 2008 Mar; 176(1):9-12. PubMed ID: 18024039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1991 Jan; 56(1):77-8. PubMed ID: 10128596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--HHS. Notice.
    Fed Regist; 1990 Oct; 55(190):40008-9. PubMed ID: 10107029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for drugs in oral fluid: drug driving and illicit drug use in a sample of Queensland motorists.
    Davey J; Freeman J
    Traffic Inj Prev; 2009 Jun; 10(3):231-6. PubMed ID: 19452364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Workplace testing of drugs of abuse and psychotropic drugs].
    Mura P; Saussereau E; Brunet B; Goullé JP
    Ann Pharm Fr; 2012 May; 70(3):120-32. PubMed ID: 22655580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-testing methods and reliability.
    Fretthold DW
    J Psychoactive Drugs; 1990; 22(4):419-28. PubMed ID: 2096186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hair testing is taking root.
    Cooper GA
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):516-30. PubMed ID: 21868416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.